Drugs / IMP1
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05890703 Comparator | Jun → Oct 2023 | ecthyma, ulcer of lower limbs | Juerg Hafner | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IMP1 | “IMP1 (EMLA 5% cream)” NCT05890703 ↗ |
| Known as | EMLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05890703 ↗ |